February 11, 2026

Universal Aspirin in High-Risk Pregnancies?

Direct dispensation at first prenatal visit delays onset, reduces rates in high-risk population without increasing hemorrhage.

Conexiant

February 09, 2026

Managing Idiopathic Acute Pancreatitis

Expert panel weighs evidence for genetic testing, cholecystectomy, and ERCP in patients with unexplained acute pancreatitis amid limited guideline direction.

Conexiant

January 15, 2026

How Treatment Is Given May Matter Most

Researchers find no severity differences by anorexia duration, note potential iatrogenic effects

Conexiant

December 15, 2025

Genetic Testing Uncovers Hidden Cancer Risk

Population screening identifies pathogenic variants in patients who wouldn't qualify under current guidelines

Conexiant

December 09, 2025

How AI Is Ushering in a New Era in Cancer Care

On October 30, 2025, Google Cloud held its second annual Cancer AI Symposium to explore how artificial intelligence (AI) is advancing cancer research, diagnosis, and treatment, in unparalleled ways. H...

The ASCO Post

November 21, 2025

Positive trends in chronic HCV mortality 

“DAAs have revolutionized the management of HCV by making it a curable disease.”

Conexiant

November 21, 2025

Tirzepatide tops semaglutide for cardiometabolic protection in MASLD

The study authors recommend prospective head-to-head trials to validate the findings.

Conexiant

November 21, 2025

ALD-related HCC mortality surges 

 The findings underscore the urgent need for targeted prevention strategies among high-risk group.

Conexiant

November 20, 2025

New score challenges old predictors

"MERAGE has superior performance for predicting return to drinking (RTD) compared to HRAR in AH."

Conexiant